Denali Capital extends business combination deadline to Oct 11, 2024 via trust deposit

Semnur Pharmaceuticals, Inc.

Deposited $15,063.74 into trust to extend deadline one month from Sept 11 to Oct 11, 2024.
Funding from Scilex Holding (SCLX) convertible promissory note up to $180,000, zero interest.
Note convertible into DECA Class A shares at $10.00 per share upon business combination close.
Remaining $149,899.52 of note principal available to fund further monthly extensions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.